Navigation Links
Newly Approved HIV Drug Shows Great Promise
Date:1/30/2008

Pricing Level Should Improve Access

WASHINGTON, Jan. 30 /PRNewswire/ -- The AIDS Institute, a national public policy research, advocacy, and education organization, is encouraged with the FDA's approval of the first new non-nucleoside reverse transcriptase inhibitor (NNRTI) in nearly a decade. TMC125/etravirine was developed by Tibotec Pharmaceuticals, Ltd. and will be marketed in the U.S. by Tibotec Therapeutics as Intelence(R), a division of Ortho Biotech Products, L.P. The company announced introductory pricing for the new NNRTI at $21.80 per day, which is substantially lower than other recently introduced antiretrovirals.

In a Title II Community AIDS National Network release dated January 19, 2008, Dr. Donna Christian-Chistensen, Chair of the Congressional Black Caucus Health Brain Trust stated: "The efficacy that Intelence (TMC125/etravirine) has shown in the DUET studies is impressive. Intelence is an important new HIV medication that, for the first time, re-opens the NNRTI class to patients with NNRTI-resistant virus. We applaud Tibotec for its efforts to make this innovative new medication available and accessible to people living with HIV."

The U.S. Food and Drug Administration (FDA) granted accelerated approval to the anti-HIV medication. This is the first non-nucleoside reverse transcriptase inhibitor (NNRTI) to show antiviral activity in treatment- experienced adult patients with HIV resistant to an NNRTI and other antiretroviral (ARV) agents. Intelence, in combination with other antiretroviral agents, is indicated for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in antiretroviral treatment- experienced adult patients, who have evidence of viral replication and HIV-1 strains resistant to an NNRTI and other ARV agents. This indication is based on Week 24 analyses from two randomized, double-blind, placebo-controlled trials of Intelence. Both studies were conducted in clinically advanced
'/>"/>

SOURCE The AIDS Institute
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
2. Sixty-One Percent of Newly Diagnosed Parkinsons Disease Patients Do Not Receive Any Drug Treatment in the First Year of Diagnosis
3. Phase III Clinical Trial in Newly Diagnosed Multiple Myeloma Stopped Early Due to Highly Significant Efficacy Advantage of VELCADE(R) (Bortezomib) for Injection Based Therapy Across All Endpoints
4. Newly Published Phase II Study Shows the Investigational Drug Vandetanib Prolongs Progression-Free Survival in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
5. New Data to Support VELCADE(R) (Bortezomib) For Injection Based Therapies as Setting New Standards in The Care of Newly Diagnosed Patients With Multiple Myeloma
6. Oncology Drugs Development Update - Worldwide Markets and Forecasts of Approved EGFr/HEr2 Inhibitors, Treatment Costs, Pathway Analysis, Current and Expanded Clinical Indications, and Novel Agents in Development
7. Norditropin(R) Approved for Treatment of Children with Short Stature Associated with Turner Syndrome
8. Norditropin(R) Approved for Treatment of Children with Short Stature Associated with Turner Syndrome
9. Nexavar First FDA-Approved Drug Therapy for Liver Cancer
10. Iomai Trial Shows 100 Percent Immune Response in Elderly Subjects Vaccinated With Novel Travelers Diarrhea Patch Vaccine
11. Study Shows Combination Therapy Incorporating AVODART(R) and Tamsulosin Provides Continuous Symptom Improvement Over 2 Years
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... , May 22, 2013  Heska Corporation (NASDAQ: HSKA, "Heska" ... specialty products, announced today that the Company will present at ... 29, 2013 at the Le Parker Meridian hotel, 119 W. ... . The presentation is scheduled to begin at 2:15 ... About Heska Heska Corporation (NASDAQ: HSKA ...
(Date:5/22/2013)... Attorney Advertising -- Bronstein, Gewirtz & Grossman, ... purchasers of the securities of AMAG Pharmaceuticals, Inc. ... investigation focuses on whether the Company and its ... May 22, 2013, Shares of AMAG dropped $2.69 ... announced in regulatory filing that it has been ...
(Date:5/22/2013)... , May 22, 2013 JenaValve Technology, Inc., ... valve implantation (TAVI) systems for the treatment of aortic valve ... J enaValve Eval U ation of Long Term P ... S E vere Ao R tic Stenosis (JUPITER) Registry at ... post-market registry to evaluate five-year long term safety and effectiveness ...
Breaking Medicine Technology:Bronstein, Gewirtz & Grossman, LLC Announces Investigation of AMAG Pharmaceuticals, Inc. 2First Results Of The JUPITER Registry On Long Term Performance And Safety Of The Transapical JenaValve TAVI System 2First Results Of The JUPITER Registry On Long Term Performance And Safety Of The Transapical JenaValve TAVI System 3First Results Of The JUPITER Registry On Long Term Performance And Safety Of The Transapical JenaValve TAVI System 4
(Date:5/22/2013)... (PRWEB) May 22, 2013 The Muscular ... against muscular dystrophy at the annual Charlotte Muscle Team ... to help Charlotte-area families living with muscle disease. ... year's event to support MDA families,” said MDA Divisional ... who were partnered with a "Buddy" to make their ...
(Date:5/22/2013)... 22, 2013 Zensah® Compression Apparel released ... article titled "Breast pain while running affects ... could help." According to the article, a British ... substantial amount suffer from breast pain while running but ... the issue. , Zensah emphasizes the importance for ...
(Date:5/22/2013)... study shows there is a gender gap when it ... one that does not appear to exist in ... had higher levels of self-regulation than boys. Self-regulation is ... impulses, follow directions, and persist on a task. It ... in past studies by Oregon State University researchers. ...
(Date:5/22/2013)... 22, 2013 People in the United States ... to water shortages. In much of the world, water shortages ... advocate, Sharon Kleyne. She warns against taking water for granted ... is available so easily in the United States. , Sharon ... Water radio show, heard live or by podcast on World ...
(Date:5/22/2013)... New York (PRWEB) May 22, 2013 ... version of the DePuy Pinnacle Hip Replacement System continue ... Texas Federal Court, Bernstein Liebhard LLP reports. According ... directed DePuy Orthopaedics to produce monitoring reports associated with ... the company’s medical device marketing practices. Plaintiffs maintained ...
Breaking Medicine News(10 mins):Health News:Charlotte Muscle Team Event Raises $300,000 in the Fight Against Muscle Disease 2Health News:Zensah® Comments on New York Daily News Article Examining How Better Sports Bra Could Help Women Marathoners 2Health News:Zensah® Comments on New York Daily News Article Examining How Better Sports Bra Could Help Women Marathoners 3Health News:'Boys will be boys' in US, but not in Asia 2Health News:'Boys will be boys' in US, but not in Asia 3Health News:Water Advocate Sharon Kleyne Announces Water Conservation Appreciation 2Health News:DePuy Pinnacle Lawsuit News: Bernstein Liebhard LLP Notes New Order in Federal Pinnacle Litigation Requiring Production of Monitoring Reports from Federal Investigation 2Health News:DePuy Pinnacle Lawsuit News: Bernstein Liebhard LLP Notes New Order in Federal Pinnacle Litigation Requiring Production of Monitoring Reports from Federal Investigation 3
... adherence counseling around the time of HIV treatment initiation ... sub-Saharan Africa, according to a recent study in ... of Global Health at University of Washington, who works ... Nairobi, Kenya. The study published March 1 also ...
... By Alan Mozes HealthDay Reporter , WEDNESDAY, March 2 ... may claim bragging rights. But when it comes to the average ... to the north, a new study of adult obesity rates in ... third of all Americans are now obese, beating out Canada by ...
... bright yellow spice from south Asia belonging to the ... and ancient wisdom suggests that it,s also good for ... Aviv University researchers have discovered that turmeric,s active ingredient ... anti-inflammatory drugs used to fight colon cancer when used ...
... WEDNESDAY, March 2 (HealthDay News) -- Hearing loss affects nearly ... than whites to have hearing problems, a new study shows. ... aged 70 and older who took part in the 2005-06 ... them had hearing loss that ranged from mild to severe. ...
... Reporter , TUESDAY, March 1 (HealthDay News) -- Both ... the risk for breast cancer among postmenopausal women, new ... or no connection between breast cancer and smoking, as ... surfacing for the first time, experts noted. "The ...
... By Steven Reinberg HealthDay Reporter , TUESDAY, ... that the U.S. Food and Drug Administration approves medical ... Many heart-related devices win FDA approval without being adequately ... so. This means that heart valves, pacemakers, ...
Cached Medicine News:Health News:Study in PLoS: Intensive adherence counseling to HIV treatment improves patient outcomes 2Health News:In Battle of the Bulge, Canada Trumps U.S. 2Health News:In Battle of the Bulge, Canada Trumps U.S. 3Health News:In Battle of the Bulge, Canada Trumps U.S. 4Health News:Fighting cancer at your local Indian restaurant 2Health News:Study Finds Smoking Linked to Breast Cancer Risk 2Health News:Study Finds Smoking Linked to Breast Cancer Risk 3Health News:Heart Devices Not Tested Enough in Women: Study 2Health News:Heart Devices Not Tested Enough in Women: Study 3
The Codman anterior cervical plate is designed for immediate internal fixation of the cervical spine following bone grafting procedures....
... system is a family of plates that ... for consistent, reliable fixation of plate to ... backout. This innovative design eliminates the need ... your screws and the swivel ring automatically ...
... a compact and quiet, yet powerful ... psi/8 bar, it provides more power ... noticeable noise reduction. A small, compact ... enhanced ergonomic handpiece to produce a ...
The stereotactic frame has been specifically designed for a radiosurgery procedure and can be used instead of traditional expensive frames....
Medicine Products: